Scilex Holding Future Growth
Future criteria checks 1/6
Scilex Holding is forecast to grow earnings and revenue by 25.2% and 18.6% per annum respectively while EPS is expected to grow by 43.2% per annum.
Key information
25.2%
Earnings growth rate
43.2%
EPS growth rate
Pharmaceuticals earnings growth | 23.9% |
Revenue growth rate | 18.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 20 Dec 2024 |
Recent future growth updates
Recent updates
Analysts Just Shaved Their Scilex Holding Company (NASDAQ:SCLX) Forecasts Dramatically
Jun 14It's Down 33% But Scilex Holding Company (NASDAQ:SCLX) Could Be Riskier Than It Looks
Apr 24Scilex Holding Company's (NASDAQ:SCLX) 35% Price Boost Is Out Of Tune With Revenues
Feb 28Risks To Shareholder Returns Are Elevated At These Prices For Scilex Holding Company (NASDAQ:SCLX)
Dec 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 81 | -82 | N/A | 6 | 2 |
12/31/2025 | 92 | -69 | N/A | -8 | 3 |
12/31/2024 | 61 | -89 | N/A | 5 | 3 |
6/30/2024 | 51 | -172 | 12 | 12 | N/A |
3/31/2024 | 47 | -161 | -4 | -4 | N/A |
12/31/2023 | 47 | -167 | -21 | -21 | N/A |
9/30/2023 | 45 | -163 | -16 | -16 | N/A |
6/30/2023 | 46 | -54 | -19 | -19 | N/A |
3/31/2023 | 42 | -45 | -20 | -18 | N/A |
12/31/2022 | 38 | -23 | -23 | -21 | N/A |
9/30/2022 | 34 | -47 | -29 | -26 | N/A |
6/30/2022 | 31 | -81 | -38 | -36 | N/A |
3/31/2022 | 33 | -78 | -35 | -35 | N/A |
12/31/2021 | 31 | -88 | -29 | -29 | N/A |
12/31/2020 | 24 | -48 | -31 | -31 | N/A |
12/31/2019 | 21 | -179 | -61 | -60 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SCLX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SCLX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SCLX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SCLX's revenue (18.6% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: SCLX's revenue (18.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SCLX's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 10:47 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Scilex Holding Company is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
James Molloy | Alliance Global Partners |
Mayank Mamtani | B. Riley Securities, Inc. |
Raghuram Selvaraju | H.C. Wainwright & Co. |